INS and type 2 diabetes mellitus: Different meta-analyses have demonstrated that TZP is more effective compared to insulin and GLP-1RA in decreasing weight and lowering glycemia, and does not increase the cardiovascular risk or the risk of adverse events, promising a new approach for the management of type 2 diabetes [23-24].